Wellstone Filters Sciences, Inc., (OTC Bulletin Board: WFLR) the leading reduced-risk cigarette filter technology company lauds a recent lawsuit filed by Reynolds American and Lorillard challenging new FDA legislation in Federal Court. The lawsuit challenges various provisions of a recent bill that radically expands the FDA's authority to regulate cigarettes and cigarette substitutes, including alternative technologies such as Reduced Exposure Products. The Reynolds suit alleges that the radical expansion of warning requirements in the bill runs afoul of the First Amendment. Other critics refer to the legislation colloquially as the "Marlboro Monopoly Act of 2009" because of Philip Morris' close collaboration in the drafting of the bill and the expansive authority it vests in the FDA to further limit cigarette advertising and thereby insulate Philip Morris' market share from any new competition.
The suit does not challenge broader provisions of the bill that empower the FDA to review and approve "modified risk" products such as Reduced Exposure Products prior to their release and distribution to the consuming public.
The suit does not challenge broader provisions of the bill that empower the FDA to review and approve "modified risk" products such as Reduced Exposure Products prior to their release and distribution to the consuming public.
